Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
Eric H. Raabe(Johns Hopkins University), John M. Maris(Children's Hospital of Philadelphia), Cynthia Winter(Children's Hospital of Philadelphia), D J Maris(Children's Hospital of Philadelphia), Nora Wasserman(University of Pennsylvania), Yaël P. Mossé(Children's Hospital of Philadelphia), Michael P. LaQuaglia(Memorial Sloan Kettering Cancer Center), Mark L. Laudenslager(University of Colorado Anschutz Medical Campus), Kristina A. Cole(Children's Hospital of Philadelphia)
Cited by 154
Related Papers
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427